Israel Englander Adial Pharmaceuticals, Inc. Transaction History

Millennium Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$28.0 - $53.25 $1.11 Million - $2.1 Million	39,490 New	39,490 $53,000
Q1 2022 May 16, 2022	SELL	$45.0 - $69.0 $933,570 - $1.43 Million	-20,746 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$62.25 - $104.5 $230,138 - $386,336	3,697 Added 21.68%	20,746 $56,000
Q3 2021 Nov 15, 2021	BUY	$57.75 - $116.75 $984,579 - $1.99 Million	17,049 New	17,049 $73,000
Q2 2019 Aug 14, 2019	SELL	N/A	-58,461 Closed	0 $0
Q1 2019 May 14, 2019	BUY	N/A	58,461 New	58,461 $201,000
Q4 2018 Feb 14, 2019	SELL	N/A	-16,966 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	N/A	16,966 New	16,966 $50,000

5.5K

Ticker ADIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,854,000
Market Cap $26M
Description
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focu...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.